Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-629 in Sjögren-Larsson Syndrome
NCT05443685Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Jan 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acloproxalap in Sjögren-Larsson syndrome (SLS), sponsored by University of Nebraska. Started Jan 2023; status: completed.
02
Drugs
acloproxalap
03
Conditions
Sjögren-Larsson syndrome (SLS)
Beyond the preview
Go deeper on NCT05443685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05443685.